T cell receptor gamma joining segment P1 (TRGJP1)

**T cell receptor gamma joining segment P1 (TRGJP1)** is a designated joining (J) gene segment within the human T cell receptor gamma (TRG) locus on chromosome 7[5][1]. It functions as part of the genetic recombination machinery that assembles variable (V), joining (J), and constant (C) gene segments to create the gamma chain of the T cell receptor (TCRγ), which is expressed on a subset of T cells (γδ T cells). The joining segment provides coding sequence for the CDR3 region of the TCRγ, crucial for antigen recognition diversity[5][3]. TRGJP1 is not a receptor or protein, nor is it a direct therapeutic target; rather, it is a germline DNA sequence with no known direct interactions with drugs, and is not used as a clinical biomarker. It is essential for normal thymocyte development but is not, by itself, the focus of pharmacologic interventions[5][3][1]. **Key clarifications:** - TRGJP1 is not a standalone receptor or molecule but a gene segment involved in the recombination of the T cell receptor gamma chain[5]. - It is incorrectly described as a therapeutic target, enzyme, protein, or receptor; its function is strictly genomic and developmental[5][1]. - No known drugs interact specifically with TRGJP1, and it is not itself a marker for disease or therapy response[1][5]. If you are searching for the cellular target commonly referred to as the "T cell receptor gamma/delta" or a surface receptor for drug targeting, the correct canonical entry would be "T cell receptor gamma/delta" (TCRγδ; not TRGJP1)[3][4].

Other names

JP1T-cell receptor gamma joining P1T-cell receptor gamma joining segment JP1TCRGJP1